バイオ分析検査サービス市場：タイプ、用途、エンドユーザー別-2025-2030年の世界予測

バイオ分析検査サービス市場は、2023年に43億3,000万米ドルと評価され、2024年には47億4,000万米ドルに達すると予測され、CAGR 9.63%で成長し、2030年には82億4,000万米ドルに達すると予測されています。

バイオ分析検査サービス市場には、生体系におけるバイオマーカーや医薬品の検出・定量に用いられるさまざまな分析手法が含まれます。生物製剤の複雑化や新薬のパイプラインの増加により、規制当局の承認や品質保証のための詳細かつ正確な検査が必要不可欠となっています。これらのサービスは、薬物動態学、薬力学、生物学的同等性、毒性学研究などの用途があり、製薬、バイオテクノロジー、医薬品開発業務受託機関などの最終用途産業にサービスを提供しています。慢性疾患の急増、急成長する生物製剤産業、個別化医療の進歩は重要な成長促進要因であり、バイオ分析能力の拡大が強く求められていることを示しています。

市場の成長は、正確な定量のための液体クロマトグラフィー・タンデム質量分析（LC-MS/MS）などの技術的進歩や、コアコンピタンスに集中するための製薬会社による研究開発活動のアウトソーシングの増加の影響を受けています。新たなビジネスチャンスとしては、バイオマーカー検査に対する需要の高まりや、個別化治療の進展によるコンパニオン診断におけるバイオ分析検査の利用の増加が挙げられます。企業は、市場の潜在力を活用するために、これらの急成長分野に投資すべきです。しかし、競合情勢としては、サービスプロバイダー間の競争の激化、規制状況の厳しさ、継続的な技術アップグレードの必要性などがあり、コスト負担が大きいという課題があります。

技術革新と研究のために、企業は費用対効果の高い迅速な検査手法の開発、データ解析のためのAIと機械学習の統合、細胞ベースのアッセイ検査における機能拡張を模索すべきです。ダイナミックな競争を特徴とする市場では、技術の進歩や進化する顧客要件への継続的な適応が必要です。企業は、提供するサービスを強化し、国際的な規制基準への準拠を維持することで、競争優位性を獲得することができます。最先端のラボ、熟練した人材、戦略的パートナーシップへの投資は、市場の抑制要因を効果的に乗り越えながら現在の成長機会を活用するための賢明な推奨事項です。

市場力学：急速に進化するバイオ分析検査サービス市場における主要市場インサイトの解明

バイオ分析検査サービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 生物製剤およびバイオシミラーの分析試験への注目の高まり
  • 製薬・バイオ医薬品業界における研究開発費の増加
  • クオリティ・バイ・デザインアプローチの採用増加
• 市場抑制要因
  • 大手企業が直面する価格圧力と熟練専門家の不足
• 市場機会
  • 専門的なバイオ分析検査サービスに対する需要の高まり
  • 自社で試験を実施するよりもアウトソーシングした方が経済効率が高まること
  • バイオ分析検査サービスにおける技術の進歩と臨床試験の承認の出現
• 市場の課題
  • 独自の生物分析試験アプローチを必要とする革新的製剤に関する懸念

ポーターの5つの力：バイオ分析検査サービス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオ分析検査サービス市場における外部からの影響の把握

外部マクロ環境要因は、バイオ分析検査サービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオ分析検査サービス市場における競合情勢の把握

バイオ分析検査サービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオ分析検査サービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオ分析検査サービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオ分析検査サービス市場における成功への道筋を描く

バイオ分析検査サービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 生物製剤およびバイオシミラーの分析試験への注目の高まり
    • 医薬品およびバイオ医薬品業界における研究開発費の増加
    • 設計による品質アプローチの採用増加
  • 抑制要因
    • 大手企業が直面する価格圧力と熟練した専門家の不足
  • 機会
    • 専門的なバイオ分析検査サービスの需要増加
    • 社内調査よりもアウトソーシングのほうが経済効率が上がる
    • 技術の進歩と臨床試験の承認の出現バイオ分析検査サービス
  • 課題
    • 独自の生体分析試験アプローチを必要とする革新的な製剤に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオ分析検査サービス市場：タイプ別

• バイオマーカー検査
• 細胞ベースのアッセイ
  • 細菌細胞ベースのアッセイ
  • ウイルス細胞ベースのアッセイ
• メソッド開発の最適化と検証
• 薬物動態試験
• 血清学、免疫原性、中和抗体
• ウイルス検査
  • 体外ウイルス学検査
  • 生体内ウイルス検査
  • 種特異的ウイルスPCRアッセイ

第7章 バイオ分析検査サービス市場：用途別

• 心臓病学
• 消化器内科
• 感染症
• 神経学
• 腫瘍学

第8章 バイオ分析検査サービス市場：エンドユーザー別

• 契約開発および製造組織
• 契約調査機関
• 製薬・バイオ医薬品企業

第9章 南北アメリカのバイオ分析検査サービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のバイオ分析検査サービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのバイオ分析検査サービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Absorption Systems LLC
• Almac Group Limited
• Altasciences
• BioAgilytix Labs, LLC
• Celerion, Inc.
• Charles River Laboratories International, Inc.
• Eurofins Scientific SE
• Frontage Laboratories, Inc.
• Icon PLC
• Intertek Group PLC
• IQVIA Holdings Inc.
• Laboratory Corporation of America Holdings
• LGC Limited
• Lotus Labs Pvt. Ltd.
• Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
• Medpace Holdings, Inc.
• NorthEast BioAnalytical Laboratories LLC
• Pace Analytical Services LLC
• Parexel International Corporation
• PPD Inc.
• Q2 Solutions
• SGS Societe Generale de Surveillance SA
• Syneos Health, LLC
• WuXi AppTec Co., Ltd.

LIST OF FIGURES

• FIGURE 1. BIOANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BIOANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BIOANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOANALYTICAL TESTING SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BACTERIAL CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIRAL CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY METHOD DEVELOPMENT OPTIMIZATION & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACOKINETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SEROLOGY, IMMUNOGENICITY, & NEUTRALIZING ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VITRO VIROLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VIVO VIROLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECIES-SPECIFIC VIRAL PCR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 50. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 76. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 77. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. CHINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 81. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 82. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. ITALY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. ITALY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 167. ITALY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 168. ITALY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. ITALY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. POLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. POLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 187. POLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 188. POLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. POLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. QATAR BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. QATAR BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 192. QATAR BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 193. QATAR BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. QATAR BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY VIROLOGY TESTING, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 240. BIOANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 241. BIOANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Bioanalytical Testing Services Market was valued at USD 4.33 billion in 2023, expected to reach USD 4.74 billion in 2024, and is projected to grow at a CAGR of 9.63%, to USD 8.24 billion by 2030.

The bioanalytical testing services market encompasses a range of analytical methods employed to detect and quantify biomarkers and pharmaceuticals in biological systems. It is essential due to the increasing complexity of biologics and a growing pipeline of new drugs necessitating detailed and accurate testing for regulatory approvals and quality assurance. These services find applications in pharmacokinetics, pharmacodynamics, bioequivalence, and toxicology studies, serving end-use industries like pharmaceuticals, biotechnology, and contract research organizations. A surge in chronic diseases, the burgeoning biologic industry, and advances in personalized medicine are significant growth drivers, indicating a strong necessity for expanded bioanalytical capabilities.

Market growth is influenced by technological advancements such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) for accurate quantitation and increased outsourcing of R&D activities by pharmaceutical companies to focus on core competencies. Emerging opportunities include the growing demand for biomarker testing and the increasing use of bioanalytical testing in companion diagnostics due to advancements in personalized therapy. Companies should invest in these burgeoning fields to capitalize on market potential. However, the bioanalytical testing services market faces challenges, including high competition among service providers, strict regulatory landscapes, and the need for continuous technological upgrades, which can be cost-prohibitive.

For innovation and research, companies should explore developing cost-effective and rapid testing methodologies, AI and machine learning integration for data analysis, and expanding capabilities in cell-based assay testing. The market, characterized by dynamic competition, necessitates continuous adaptation to technological advancements and evolving client requirements. Companies can gain a competitive edge by enhancing their service offerings and maintaining compliance with international regulatory standards. Investments in state-of-the-art laboratories, skilled personnel, and strategic partnerships are prudent recommendations to leverage the current growth opportunities while navigating market limitations effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioanalytical Testing Services Market

The Bioanalytical Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising focus on the analytical testing of biologics and biosimilars
  • Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
  • Rising adoption of the quality by design approach
• Market Restraints
  • Pricing pressure and dearth of skilled professionals faced by major players
• Market Opportunities
  • Rising demand for specialized bioanalytical testing services
  • Increasing economic efficiency offered for outsourcing rather than conducting an in-house study
  • Emergence of technological advancements and approvals of clinical trials in the bioanalytical testing services
• Market Challenges
  • Concerns regarding innovative formulations demanding a unique bioanalytical testing approach

Porter's Five Forces: A Strategic Tool for Navigating the Bioanalytical Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioanalytical Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioanalytical Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioanalytical Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioanalytical Testing Services Market

A detailed market share analysis in the Bioanalytical Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioanalytical Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioanalytical Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioanalytical Testing Services Market

A strategic analysis of the Bioanalytical Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioanalytical Testing Services Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Almac Group Limited, Altasciences, BioAgilytix Labs, LLC, Celerion, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, Frontage Laboratories, Inc., Icon PLC, Intertek Group PLC, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, LGC Limited, Lotus Labs Pvt. Ltd., Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd., Medpace Holdings, Inc., NorthEast BioAnalytical Laboratories LLC, Pace Analytical Services LLC, Parexel International Corporation, PPD Inc., Q2 Solutions, SGS Societe Generale de Surveillance SA, Syneos Health, LLC, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Bioanalytical Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Biomarker Testing, Cell-Based Assays, Method Development Optimization & Validation, Pharmacokinetic Testing, Serology, Immunogenicity, & Neutralizing Antibodies, and Virology Testing. The Cell-Based Assays is further studied across Bacterial Cell-Based Assays and Viral Cell-Based Assays. The Virology Testing is further studied across In Vitro Virology Testing, In Vivo Virology Testing, and Species-Specific Viral PCR Assays.
• Based on Application, market is studied across Cardiology, Gastroenterology, Infectious Diseases, Neurology, and Oncology.
• Based on End User, market is studied across Contract Development & Manufacturing Organizations, Contract Research Organizations, and Pharmaceutical & Biopharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising focus on the analytical testing of biologics and biosimilars
    • 5.1.1.2. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
    • 5.1.1.3. Rising adoption of the quality by design approach
  • 5.1.2. Restraints
    • 5.1.2.1. Pricing pressure and dearth of skilled professionals faced by major players
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising demand for specialized bioanalytical testing services
    • 5.1.3.2. Increasing economic efficiency offered for outsourcing rather than conducting an in-house study
    • 5.1.3.3. Emergence of technological advancements and approvals of clinical trials in the bioanalytical testing services
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns regarding innovative formulations demanding a unique bioanalytical testing approach
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bioanalytical Testing Services Market, by Type

• 6.1. Introduction
• 6.2. Biomarker Testing
• 6.3. Cell-Based Assays
  • 6.3.1. Bacterial Cell-Based Assays
  • 6.3.2. Viral Cell-Based Assays
• 6.4. Method Development Optimization & Validation
• 6.5. Pharmacokinetic Testing
• 6.6. Serology, Immunogenicity, & Neutralizing Antibodies
• 6.7. Virology Testing
  • 6.7.1. In Vitro Virology Testing
  • 6.7.2. In Vivo Virology Testing
  • 6.7.3. Species-Specific Viral PCR Assays

7. Bioanalytical Testing Services Market, by Application

• 7.1. Introduction
• 7.2. Cardiology
• 7.3. Gastroenterology
• 7.4. Infectious Diseases
• 7.5. Neurology
• 7.6. Oncology

8. Bioanalytical Testing Services Market, by End User

• 8.1. Introduction
• 8.2. Contract Development & Manufacturing Organizations
• 8.3. Contract Research Organizations
• 8.4. Pharmaceutical & Biopharmaceutical Companies

9. Americas Bioanalytical Testing Services Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bioanalytical Testing Services Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bioanalytical Testing Services Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Absorption Systems LLC
• 2. Almac Group Limited
• 3. Altasciences
• 4. BioAgilytix Labs, LLC
• 5. Celerion, Inc.
• 6. Charles River Laboratories International, Inc.
• 7. Eurofins Scientific SE
• 8. Frontage Laboratories, Inc.
• 9. Icon PLC
• 10. Intertek Group PLC
• 11. IQVIA Holdings Inc.
• 12. Laboratory Corporation of America Holdings
• 13. LGC Limited
• 14. Lotus Labs Pvt. Ltd.
• 15. Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
• 16. Medpace Holdings, Inc.
• 17. NorthEast BioAnalytical Laboratories LLC
• 18. Pace Analytical Services LLC
• 19. Parexel International Corporation
• 20. PPD Inc.
• 21. Q2 Solutions
• 22. SGS Societe Generale de Surveillance SA
• 23. Syneos Health, LLC
• 24. WuXi AppTec Co., Ltd.